Health Condition 1: null- Hair Loss patients
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Healthy male and female subjects who are 18 to 40 years of age. 2.Patients with hair loss disorders such as telogen effluvium (as first line therapy), chronic female pattern hair loss, Androgenetic Alopecia (Stage I â?? IV) (as combination with minoxidil) 3.Site involved - scalp
Exclusion criteria
Exclusion criteria: 1.Androgenetic alopecia (Stage V and beyond) 2.Evidence of dermatological disease as revealed by history, physical examination or laboratory assessment which may interfere with administration or assessment of study medication 3.Current use of dermatological drugs / preparations which may interfere with study evaluation 4.Intolerance to any of ingredients of the formulation 5.Current alcohol or drug abuse 6.Subjects viewed by the investigator as not being able to complete the study. 7.Hair product such as hair dyes, sprays, setting gels and restorers 8.Any procedures for hair enhancement and curling or straightening techniques 9.Pregnant or breastfeeding women 10.Patient or having participated in a clinical trial in the month before
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| â?¢Improvement in hair growth by clinical digital photography Timepoint: Baseline & 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| â?¢Percentage of patients responding to the therapy â?¢Hair Pull test (or additional Hair Shedding test) â?¢Adverse event assessment â?¢Acceptability of the treatment â?¢Tolerance of the treatment â?¢Global assessment for efficacy by Investigator and Patient â?¢Global assessment for tolerability by Investigator and Patient Timepoint: Baseline & 8 weeks | — |
Countries
India
Contacts
Abbott Healthcare Pvt Ltd